Discover your next big idea in food packaging & processing this Sept.
Experience a breakthrough in food packaging & processing—explore solutions from 2,300 suppliers spanning all industries at PACK EXPO Las Vegas.
REGISTER TODAY & SAVE

PCI Pharma Services Invests Over $365 Million in EU, U.S. Facilities

The facilities support clinical and commercial supply of advanced drug delivery and drug-device combination products.

PCI has broken ground on a new packaging and device assembly services facility at its CityNorth Dublin campus. The plant will provide increased capacity for the final assembly, labeling and packaging of injectable drug products including vials, prefilled syringes, and drug-device combination products such as auto-injectors.
PCI has broken ground on a new packaging and device assembly services facility at its CityNorth Dublin campus. The plant will provide increased capacity for the final assembly, labeling and packaging of injectable drug products including vials, prefilled syringes, and drug-device combination products such as auto-injectors.
PCI Pharma Services

Key takeaways:

·      PCI is investing more than $365 million in infrastructure supporting the clinical and commercial-scale final assembly and packaging of drug-device combination products.

·       The company has acquired a new pharma device assembly and packaging facility near Dublin, Ireland.

·       In the United States, PCI has plans for an ambitious 545,000-square-foot expansion at its campus in Rockford, Illinois.

  

PCI Pharma Services, (“PCI”) a leading global contract development and manufacturing organization (CDMO) focused on biopharma’s most complex therapies, is investing more than $365 million in infrastructure supporting the clinical and commercial-scale final assembly and packaging of drug-device combination products utilizing advanced drug delivery systems, with an emphasis on injectable formats. Comprising new and expanded facilities in both Europe and North America, the effort is part of PCI’s global investment plan, is anchored and funded by recent new business, and is designed to augment and accommodate future growth.

For PCI, the investments build upon 20-plus years of biologics expertise, a leadership position highlighted by the company’s world-class Biotech Center of Excellence in Philadelphia. That location employs precision handling equipment for prefilled syringes, syringe assembly and labeling, vial labeling and cartoning, and autoinjector assembly. Recently, PCI heavily invested in complex, automated advanced drug delivery technologies to enhance capabilities and capacities at this facility, ensuring it remains at the forefront of innovation.

Combined, the new projects further bolster PCI’s ability to manage the full lifespan of such products, from sterile drug product development and manufacturing through clinical trial supply, product launch and commercialization.

Dairy Food & Beverage Innovations Report
Discover cutting-edge packaging and processing solutions in the inaugural Packaging World/ProFood World Innovations Report. From high-speed filling machines to mono-material lids, see how the latest advancements from PACK EXPO International 2024 are driving safety, sustainability, and extended shelf life—shaping the future of dairy food and beverage packaging.
Access Now
Dairy Food & Beverage Innovations Report
Break out of the ordinary: see what’s new in food packaging & processing
<strong>At PACK EXPO Las Vegas you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us this September to experience a breakthrough in food packaging and processing.</strong>
REGISTER NOW AND SAVE!
Break out of the ordinary: see what’s new in food packaging & processing